Global Nucleic Acid Isolation and Purification Market 2017-2021
About Nucleic Acid Isolation and Purification
Isolation and purification of nucleic acids, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), is the basic technique used in molecular biology. These biomolecules can be isolated from any biological material for consequent downstream, analytical, or preparative purposes. The demand for DNA fingerprinting, construction of genomic or sequencing libraries, restriction fragment length polymorphism (RFLP), and polymerase chain reaction (PCR) analysis in research laboratories and industries has increased. Also, nucleic acid isolation and purification is the first step in the study of specific DNA and RNA sequences, and in the analysis of genome structure and gene expression. However, the quantity, quality, and integrity of nucleic acids will directly affect these results.
Technavio’s analysts forecast the global nucleic acid isolation and purification market to grow at a CAGR of 8.33% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global nucleic acid isolation and purification market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Nucleic Acid Isolation and Purification Market 2017-2021
Technavio recognizes the following companies as the key players in the global nucleic acid isolation and purification market: Agilent Technologies, Bio-Rad Laboratories, F.Hoffmann-La-Roche, GE Healthcare, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Abcam, Bioline, biotechrabbit, bioWORLD, Danaher, Epicentre, Hamilton, New England Biolabs, Omega Bio-tek, Promega, Qiagen, Sigma-Aldrich, and Takara Bio.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing importance of promotional activities. The nature of product coupled with the niche end-user market makes it difficult for vendors to market these products. Unlike other analysis equipment, the brand and product visibility have a limited role in the sale of these devices. Emphasis is given to improve the distribution network and increase the availability of products to the end-users.”
According to the report, one driver in the market is increasing occurrence of genetic disorder, cancer, and infectious diseases. The occurrence of genetic disorders, infectious diseases, and cancer is on the rise across the world. A genetic disorder is caused by an aberration in an individual's DNA. Aberrations can be as small as a single-base mutation in just one gene, or may involve the subtraction or addition of entire chromosome. Examples of genetic disorders include cystic fibrosis, thalassemia, and sickle cell anemia. Cancer is one of the major public health problems across the world and it is one of the leading causes of death. There are various types of cancer such as lung cancer, breast cancer, skin cancer, and colon cancer. In 2012, it was estimated that approximately 13.92 million new cases of cancer occur across the world.
Further, the report states that one challenge in the market is intense competition between local and global vendors. The emergence of low-cost equipment vendors from APAC has seriously affected the growth of the global nucleic acid isolation and purification market. The operation models of these low-cost vendors try to improve their market presence globally by offering low-cost products, which adversely affects growth and sales potential of domestic vendors. Notably, domestic vendors are forced to reduce the price of their products to remain competitive in the business environment. In developing countries such as India and China, domestic players are competing with major or leading vendors such as Agilent Technologies and Bio-Rad Laboratories. To sustain the competition, domestic players are offering their products at low prices compared with the major vendors.
Agilent Technologies, Bio-Rad Laboratories, F.Hoffmann-La-Roche, GE Healthcare, and Thermo Fisher Scientific, Abcam, Bioline, biotechrabbit, bioWORLD, Danaher, Epicentre, Hamilton, New England Biolabs, Omega Bio-tek, Promega, Qiagen, Sigma-Aldrich, and Takara Bio.